Literature DB >> 11998891

Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Xueling Wu1, Susan Jackson.   

Abstract

We examined IgA and IgM responses in parotid saliva from human immunodeficiency virus-1 (HIV-1)-infected individuals. Compared to the uninfected controls, levels of salivary secretory IgA2 were significantly increased in HIV-1-infected subjects, with higher levels in those who displayed oral manifestations of HIV- I infection. Assessed by enzyme immunoassay, about two thirds of the HIV-1-infected individuals tested positive for salivary HIV-1-specific IgA antibodies but not for salivary IgM. No clear correlations between the amount of HIV-1-specific IgA and CD4 counts or plasma viral loads were found. The proportions of HIV-1-specific IgA did not correlate with the levels of total IgA. Determined by Western blot, IgA1 accounted for the majority of anti-HIV-1 IgA antibodies in saliva. Comparisons between the specificities of plasma and salivary IgA directed to HIV-1 proteins revealed the absence of salivary anti-gp41 IgA antibodies, and lower HIV-1-specific reactivity of IgA and IgM were determined in saliva than in plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11998891     DOI: 10.1023/a:1014435920321

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  41 in total

1.  Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity.

Authors:  K P Black; J E Cummins; S Jackson
Journal:  Clin Immunol Immunopathol       Date:  1996-11

2.  Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.

Authors:  P Moja; C Tranchat; I Tchou; B Pozzetto; F Lucht; C Desgranges; C Genin
Journal:  J Infect Dis       Date:  2000-05-08       Impact factor: 5.226

3.  Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.

Authors:  O Cartry; P Moja; A Quesnel; B Pozzetto; F R Lucht; C Genin
Journal:  Clin Exp Immunol       Date:  1997-07       Impact factor: 4.330

4.  Hypergammaglobulinemia associated with human immunodeficiency virus infection.

Authors:  C B Reimer; C M Black; R C Holman; T W Wells; R M Ramirez; J A Sa-Ferreira; J K Nicholson; J S McDougal
Journal:  Monogr Allergy       Date:  1988

5.  Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.

Authors:  X S Lü; J F Delfraissy; L Grangeot-Keros; M T Rannou; J Pillot
Journal:  Res Virol       Date:  1994 Nov-Dec

6.  Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages.

Authors:  S Matsuda; S Oka; M Honda; Y Takebe; T Takemori
Journal:  Scand J Immunol       Date:  1993-11       Impact factor: 3.487

7.  Infective and anti-infective properties of breastmilk from HIV-1-infected women.

Authors:  P Van de Perre; A Simonon; D G Hitimana; F Dabis; P Msellati; B Mukamabano; J B Butera; C Van Goethem; E Karita; P Lepage
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

8.  Serum IgA-mediated neutralization of HIV type 1.

Authors:  P R Burnett; T C VanCott; V R Polonis; R R Redfield; D L Birx
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

9.  Both IgA subclasses are reduced in parotid saliva from patients with AIDS.

Authors:  F Müller; S S Frøland; M Hvatum; J Radl; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men.

Authors:  H Wolff; K Mayer; G Seage; J Politch; C R Horsburgh; D Anderson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  3 in total

Review 1.  Saliva as a diagnostic fluid.

Authors:  Daniel Malamud
Journal:  Dent Clin North Am       Date:  2011-01

Review 2.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

3.  The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection.

Authors:  Eleonora Castelletti; Sergio Lo Caputo; Louise Kuhn; Manuela Borelli; Johanna Gajardo; Moses Sinkala; Daria Trabattoni; Chipepo Kankasa; Eleonora Lauri; Alberto Clivio; Luca Piacentini; Dorothy H Bray; Grace M Aldrovandi; Donald M Thea; Francisco Veas; Manuela Nebuloni; Francesco Mazzotta; Mario Clerici
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.